Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2008
10/15/2008EP1979345A2 Novel pyridine derivatives
10/15/2008EP1979343A2 Bicyclic heteroaryl compounds as pde10 inhibitors
10/15/2008EP1979342A1 Compounds for the inhibition of integrins and use thereof
10/15/2008EP1979341A1 Trisubstituted amine compound
10/15/2008EP1979340A2 S-omeprazole magnesium
10/15/2008EP1979339A2 Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
10/15/2008EP1979338A1 Cis-4, 5-biaryl-2-heterocyclic-imidazolines as mdm2 inhibitors
10/15/2008EP1979335A2 Thiazoles as 11 beta-hsd1 inhibitors
10/15/2008EP1979334A1 Novel benzamidine derivatives, process for the preparation thereof and pharmaceutical composition comprising the same
10/15/2008EP1979332A1 Chemical compounds
10/15/2008EP1979331A1 Trisubstituted amine compounds as inhibitors of -cholesteryl ester transfer protein cetp
10/15/2008EP1979328A1 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
10/15/2008EP1979327A1 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
10/15/2008EP1979326A1 Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
10/15/2008EP1979324A2 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer's disease, neurodegeneration and dementia
10/15/2008EP1979322A1 Cyclohexyl sulfonamide derivatives having h3 receptor activity
10/15/2008EP1979321A1 Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them
10/15/2008EP1979320A2 PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS
10/15/2008EP1979319A1 Novel dual nk2/nk3-antagonists, pharmaceutical compositions comprising them and processes for their preparations
10/15/2008EP1979318A1 Amido compounds and their use as pharmaceuticals
10/15/2008EP1979317A1 Benzoisoindole derivatives for the treatment of pain
10/15/2008EP1979316A1 Benzo (f) isoindol-2-ylphenyl acetic acid derivatives as ep4 receptor agonists
10/15/2008EP1979315A2 Methods for treating hepatitis c
10/15/2008EP1979314A2 Indole sulfonamide modulators of progesterone receptors
10/15/2008EP1979311A2 Phenoxy acetic acids as ppar delta activators
10/15/2008EP1979308A1 Optical isomers of dihydro-2,3-benzodiazepines and their stereoselective synthesis
10/15/2008EP1979053A2 Product for treating the skin and mucous membranes, and relative method of preparation
10/15/2008EP1979002A2 Combination of igfr inhibitor and anti-cancer agent
10/15/2008EP1978997A1 Transdermal delivery of pharmaceutical agents
10/15/2008EP1978996A2 Small-volume oral transmucosal dosage forms
10/15/2008EP1978985A2 Anti-hyperproliferative therapies targeting hdgf
10/15/2008EP1978975A1 Composition for inhibiting adhesion
10/15/2008EP1978974A1 Methods of treating degenerative disorders with rac 1b inhibitor
10/15/2008EP1978973A2 Methods of using hedgehog kinase antagonists to inhibit hedgehog signaling and to treat hedgehog mediated disorders
10/15/2008EP1978972A1 Use of alkylglucoside esters as beta-defensin inducers
10/15/2008EP1978971A2 Arginine heteromers for topical administration
10/15/2008EP1978970A1 Contraceptive
10/15/2008EP1978969A1 Medicament comprising a hormone combination
10/15/2008EP1978968A2 Cationic steroid antimicrobial compositions for treating or preventing hiv infections
10/15/2008EP1978967A1 Quinazolinone derivatives as vanilloid antagonists
10/15/2008EP1978966A2 Tricyclic inhibitors of 5-lipoxygenase
10/15/2008EP1978965A2 Hexahydro-3h-pyrrolizin-3-ones useful as tachykinin receptor antagonists
10/15/2008EP1978964A2 Jak2 tyrosine kinase inhibition
10/15/2008EP1978963A2 2,5 diaza-bicycloý2.2.1¨heptane derivatives as calcium channel blockers
10/15/2008EP1978962A2 Compositions and methods of treatment using modulators of motonueron diseases
10/15/2008EP1978961A2 Tetralone-based monoamine reuptake inhibitors
10/15/2008EP1978960A1 Use of 6-(3-chloro-2-fluorobenzyl)-1-ý(2s)-1-hydroxy-3-methylbutan-2-yl¨-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid or salt thereof for treating retrovirus infection
10/15/2008EP1978959A2 Piperidine and piperazine derivatives
10/15/2008EP1978958A2 Ret tyrosine kinase inhibition
10/15/2008EP1978957A2 Pharmaceutical compounds that contain nanoparticles useful for treating restenotic lesions
10/15/2008EP1978956A1 Complex formulation comprising amlodipine camsylate and simvastatin and method for preparation thereof
10/15/2008EP1978955A1 New pharmaceutical compositions based on anticholinergics and andolast
10/15/2008EP1978954A2 Use of 15-lipoxygenase inhibitors for treating obesity
10/15/2008EP1978953A1 Pharmaceutical compositions containing docetaxel and a degradation inhibitor and a process for obtaining the same.
10/15/2008EP1978952A2 Therapeutic delivery of carbon monoxide
10/15/2008EP1978951A2 Combination of triazine derivatives and hmg-coa reductase inhibitors for the treatment of diabetes
10/15/2008EP1978950A2 Pharmaceutical sustained release compositions comrising in particular thyroid hormones
10/15/2008EP1978949A2 Combination preparation for improving sperm quality
10/15/2008EP1978948A2 Compounds for the treatment of metabolic disorders
10/15/2008EP1978947A2 Use of nitrooxyderivative of drug for the treatment of muscular dystrophies
10/15/2008EP1978944A2 Soft-gelatin capsule formulation
10/15/2008EP1978942A1 Compositions containing solid ibuprofen concentrates and methods of making solid ibuprofen concentrates
10/15/2008EP1978939A2 Mouth dissolving pharmaceutical composition and process for preparing the same using a high amount of silicon dioxine
10/15/2008EP1978938A1 Process for loading polymer particles with drug
10/15/2008EP1978935A1 Coated formulations
10/15/2008EP1978934A1 Bursting pellets
10/15/2008EP1978932A1 Water stabilized aerosol formulation system and method of making
10/15/2008EP1978928A1 Pharmaceutical composition and process
10/15/2008EP1978927A1 Pharmaceutical forms in film form for use in the mouth (wafer)
10/15/2008EP1978808A2 Method of reversing, preventing, delaying or stabilizing soft tissue calcification
10/15/2008EP1978807A2 Method of treating chronic kidney disease
10/15/2008EP1978804A2 Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
10/15/2008EP1896416B1 Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them
10/15/2008EP1781297B1 Novel biaromatic compounds that activate ppar type receptors, and use thereof in cosmetic or pharmaceutical compositions
10/15/2008EP1776366B1 Immunomodulating oxopyrrazolocinnolines as cd80 inhibitors
10/15/2008EP1747201B1 2h or 3h-benzo[e]indazol-1-yle carbamate derivatives, the preparation and therapeutic use thereof
10/15/2008EP1742642B1 Phosphonate analogs of hiv integrase inhibitor compounds
10/15/2008EP1708998B1 Indol-alanine derivatives as selective s1p4-agonists
10/15/2008EP1694338B1 Use of mimetics of superoxide dismutase and of reductase glutathione in the form of anticancer drugs
10/15/2008EP1693374B1 Microcrystal and medicinal preparation containing the same
10/15/2008EP1689745B1 Novel macrocycles for treating tumor diseases
10/15/2008EP1685114B1 Antibacterial and/or antiprotozoal nitroimidazole derivative compounds with urease inhibitor activity, process for preparing these compounds and use in pharmaceutical compositions and medicines.
10/15/2008EP1685105B1 Allosteric modulators of metabotropic glutamate receptors
10/15/2008EP1682109B1 The use of 1-aminocyclohexane derivatives to modify deposition of fibrillogenic as peptides in amyloidopathies
10/15/2008EP1680127B1 Benzazepine derivatives as mao-b inhibitors
10/15/2008EP1660455B1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
10/15/2008EP1660085B1 Pyridylpyrrole derivatives active as kinase inhibitors
10/15/2008EP1641771B1 Hydroxamate sulfonamides as cd23 shedding inhibitors
10/15/2008EP1638948B1 Diphenylurea derivatives and their use as chloride channel blockers
10/15/2008EP1636175B1 Phenoxyacetic acid derivatives for treating respiratory disorders
10/15/2008EP1628656B1 Gabapentin tannate in liquid and/or semi-solid dosage forms
10/15/2008EP1628655A4 Antiseptic compositions, methods and systems
10/15/2008EP1605939B1 Pharmaceutical use of 1-azabicyclo¬ 2.2.2 octanes and a method of testing compounds for the ability of activating inactive wt p53
10/15/2008EP1603901B1 Tetrahydropyran compounds as tachykinin antagonists
10/15/2008EP1587585B1 Acylsulfonamide compounds as inhibitors of rna-dependent rna (viral) polymerases
10/15/2008EP1585750B1 Narcistatin prodrugs
10/15/2008EP1569623B1 A topical nanoparticulate spironolactone formulation
10/15/2008EP1567667B1 Treatment of huntington's disease with epa
10/15/2008EP1567520B1 Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents
10/15/2008EP1567112B1 THIAZOLIDIN-4-ONES FOR INHIBITING hYAK3 PROTEINS
1 ... 3043 3044 3045 3046 3047 3048 3049 3050 3051 3052 3053 3054 3055 3056 3057 3058 3059 3060 3061 3062 3063 ... 7860